{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:55:57Z","timestamp":1768521357092,"version":"3.49.0"},"reference-count":36,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T00:00:00Z","timestamp":1703376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Hemophilia A is a hemorrhagic disorder caused by insufficient or inadequate coagulation factor VIII activity. Two different forms are described: congenital, hereditary X-linked, and acquired. Acquired hemophilia A (AHA) is a rare condition and it is defined by the production of autoantibodies neutralizing factor VIII, known as inhibitors. We report the case of a 72-year-old man with a clinical diagnosis of AHA after SARS-CoV-2 infection, which has been described in association with several hematological complications. SARS-CoV-2 infection could represent the immunological trigger for the development of autoantibodies. In our patient, SARS-CoV-2 infection preceded the hemorrhagic complications by 15 days. This lag time is in line with the other cases reported and compatible with the development of an intense immune response with autoantibody production. It is possible that since our patient was affected by type 1 diabetes mellitus, he was more prone to an immune system pathological response against self-antigens. A prompt, appropriate therapeutic intervention with activated recombinant factor VII administration and cyclophosphamide has led to rapid remission of clinical and laboratory findings.<\/jats:p>","DOI":"10.3390\/diseases12010005","type":"journal-article","created":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T20:48:37Z","timestamp":1703450917000},"page":"5","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hematological Complications in a COVID-19 Patient: A Case Report"],"prefix":"10.3390","volume":"12","author":[{"given":"Eleonora","family":"Ianu\u00e0","sequence":"first","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Universitario \u201cAgostino Gemelli\u201d, IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-7072","authenticated-orcid":false,"given":"Mario","family":"Caldarelli","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Universitario \u201cAgostino Gemelli\u201d, IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2982-3951","authenticated-orcid":false,"given":"Giuseppe","family":"De Matteis","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Universitario \u201cAgostino Gemelli\u201d, IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5378-8442","authenticated-orcid":false,"given":"Rossella","family":"Cianci","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Universitario \u201cAgostino Gemelli\u201d, IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Gambassi","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and Surgery, Catholic University, Fondazione Policlinico Universitario \u201cAgostino Gemelli\u201d, IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.20390","article-title":"Acquired Hemophilia A: A Concise Review","volume":"80","author":"Franchini","year":"2005","journal-title":"Am. J. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/hae.14548","article-title":"Acquired Bleeding Disorders","volume":"28","author":"Tiede","year":"2022","journal-title":"Haemophilia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired Hemophilia A in the United Kingdom: A 2-Year National Surveillance Study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"109","author":"Collins","year":"2007","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and Clinical Data in Acquired Hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International Recommendations on the Diagnosis and Treatment of Acquired Hemophilia A","volume":"105","author":"Tiede","year":"2020","journal-title":"Haematologica"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Zanon, E. (2023). Acquired Hemophilia A: An Update on the Etiopathogenesis, Diagnosis, and Treatment. Diagnostics, 13.","DOI":"10.3390\/diagnostics13030420"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11239-018-1750-y","article-title":"Combined Use of Antifibrinolytics and Activated Prothrombin Complex Concentrate (aPCC) Is Not Related to Thromboembolic Events in Patients with Acquired Haemophilia A: Data from FAIR Registry","volume":"47","author":"Pasca","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2141.2003.04162.x","article-title":"Acquired Haemophilia: Review and Meta-Analysis Focused on Therapy and Prognostic Factors","volume":"121","author":"Delgado","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-0030-1255442","article-title":"Recombinant Activated Factor VII: Mechanisms of Action and Current Indications","volume":"36","author":"Franchini","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/bcp.15598","article-title":"Management of Acquired Haemophilia A in Severe COVID-19: Haemostatic Bridging with Emicizumab to Keep the Balance between Bleeding and Thrombosis","volume":"89","author":"Gelbenegger","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa1803550","article-title":"Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors","volume":"379","author":"Mahlangu","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/jth.15208","article-title":"Should Emicizumab Be Used in Patients with Acquired Hemophilia A?","volume":"19","author":"Tiede","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd Edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemoph. Off. J. World Fed. Hemoph."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bmj.329.7461.323","article-title":"Acquired Haemophilia A May Be Associated with Clopidogrel","volume":"329","author":"Haj","year":"2004","journal-title":"BMJ"},{"key":"ref_15","first-page":"e16579","article-title":"A Case of Acquired Hemophilia A Following SARS-CoV-2 Infection","volume":"13","author":"Hafzah","year":"2021","journal-title":"Cureus"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.jfma.2022.02.017","article-title":"A Case of Acquired Hemophilia A and Bullous Pemphigoid Following SARS-CoV-2 mRNA Vaccination","volume":"121","author":"Fu","year":"2022","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jth.15291","article-title":"A Case Report of Acquired Hemophilia Following COVID-19 Vaccine","volume":"19","author":"Radwi","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14740\/jmc3827","article-title":"Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare Complication","volume":"13","author":"Soliman","year":"2022","journal-title":"J. Med. Cases"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103577","DOI":"10.1016\/j.transci.2022.103577","article-title":"Acquired Hemophilia A Following COVID-19 Vaccination\u2014The Importance of Prompt Diagnosis: A Case Report","volume":"62","author":"Duminuco","year":"2022","journal-title":"Transfus. Apher. Sci."},{"key":"ref_20","first-page":"e21909","article-title":"Acquired Hemophilia A Post-COVID-19 Vaccination: A Case Report and Review","volume":"14","author":"Bakir","year":"2022","journal-title":"Cureus"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/00365513.2022.2092902","article-title":"Acquired Hemophilia A with SARS-CoV-2 mRNA Vaccine: First Case from Pakistan","volume":"82","author":"Rashid","year":"2022","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e12785","DOI":"10.1002\/rth2.12785","article-title":"Acquired Hemophilia Following COVID-19 Vaccination: Case Report and Review of Literature","volume":"6","author":"Happaerts","year":"2022","journal-title":"Res. Pr. Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"102915","DOI":"10.1016\/j.jaut.2022.102915","article-title":"Acute-Type Acquired Hemophilia A after COVID-19 mRNA Vaccine Administration: A New Disease Entity?","volume":"133","author":"Hosoi","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1055\/a-1579-5396","article-title":"Autoimmunity after Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A","volume":"121","author":"Farley","year":"2021","journal-title":"Thromb. Haemost."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.thromres.2022.01.017","article-title":"Four Cases of Acquired Hemophilia A Following Immunization with mRNA BNT162b2 SARS-CoV-2 Vaccine","volume":"211","author":"Leone","year":"2022","journal-title":"Thromb. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14740\/jmc3921","article-title":"Acquired Hemophilia A after SARS-CoV-2 Infection: A Case Report","volume":"13","author":"Nardella","year":"2022","journal-title":"J. Med. Cases"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Nikolina, B., Marija, M., Marija, B., Maja, M., and Dubravka, P. (2022). Acquired Hemophilia A Secondary to SARS-CoV-2 Pneumonia: A Case Report. Biochem. Medica, 32.","DOI":"10.11613\/BM.2022.030801"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/trf.16254","article-title":"De Novo Acquired Hemophilia as an Immune Dysregulation Phenomenon Following SARS-CoV-2 Infection","volume":"61","author":"Olsen","year":"2021","journal-title":"Transfusion"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1002\/ajh.25865","article-title":"The First Case of Acquired Hemophilia A Associated with SARS-CoV-2 Infection","volume":"95","author":"Franchini","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e242884","DOI":"10.1136\/bcr-2021-242884","article-title":"Severe Acquired Haemophilia Associated with Asymptomatic SARS-CoV-2 Infection","volume":"14","author":"Wang","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_31","first-page":"e30662","article-title":"Outcomes of COVID-19 in Adult Males with Hemophilia A: A Propensity Score-Matched Analysis","volume":"14","author":"Mericliler","year":"2022","journal-title":"Cureus"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","article-title":"COVID-19 and Autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sekulovski, M., Mileva, N., Vasilev, G.V., Miteva, D., Gulinac, M., Peshevska-Sekulovska, M., Chervenkov, L., Batselova, H., Vasilev, G.H., and Tomov, L. (2023). Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102813"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"015","DOI":"10.1055\/s-0042-1754389","article-title":"Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review","volume":"49","author":"Franchini","year":"2023","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and Autoimmune Disease: What Is the Evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"N\u00e9meth, M., M\u00fchl, D., Csontos, C., Nagy, \u00c1., Alizadeh, H., and Szak\u00e1cs, Z. (2023). Acquired Hemophilia A after SARS-CoV-2 Infection: A Case Report and an Updated Systematic Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092400"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/12\/1\/5\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:13Z","timestamp":1760132473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/12\/1\/5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["diseases12010005"],"URL":"https:\/\/doi.org\/10.3390\/diseases12010005","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,24]]}}}